ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
9.47
+0.06 (0.64%)
Aug 14, 2026, 4:00 PM EDT - Market closed
ADMA Biologics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 512.28 | 510.17 | 426.45 | 258.22 | 154.08 | 80.94 |
Revenue Growth | 8.04% | 19.63% | 65.16% | 67.58% | 90.36% | 91.72% |
Gross Profit Gross Profit Growth | 331.47 | 292.77 | 219.55 | 88.94 | 35.27 | 1.17 |
Operating Income Operating Income Growth | 216.5 | 191.44 | 138.98 | 22.33 | -39.37 | -57.57 |
Net Income Net Income Growth | 168.96 | 146.93 | 197.67 | -28.24 | -65.9 | -71.65 |
Earnings Per Share EPS Growth | 0.70 | 0.60 | 0.81 | -0.13 | -0.33 | -0.51 |
EPS Growth | -17.00% | -25.93% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
ADMA BioManufacturing ADMA BioManufacturing Growth | 494.71 | 493 | 415.81 | 249.74 | 144.07 | 74.94 |
Plasma Collection Centers Plasma Collection Centers Growth | - | 17.03 | 10.51 | 8.33 | 9.87 | 5.86 |
License License Growth | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 |
Revenue (Total) Revenue (Total) Growth | 512.28 | 510.17 | 426.45 | 258.22 | 154.08 | 80.94 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 136.02 | 87.63 | 103.15 | 51.35 | 86.52 | 51.09 |
Total Debt Total Debt Growth | 203.84 | 79.89 | 82.12 | 141.42 | 154.44 | 102.92 |
Net Cash (Debt) Net Cash Growth | -67.82 | 7.75 | 21.03 | -90.07 | -67.92 | -51.83 |
Net Cash Growth | - | -63.17% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.28 | 0.03 | 0.09 | -0.40 | -0.34 | -0.37 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 136.72 | 50.4 | 118.67 | 8.8 | -59.51 | -112.37 |
Capital Expenditures CapEx Growth | -20.25 | -22.58 | -8.23 | -4.77 | -13.91 | -13.51 |
Free Cash Flow Free Cash Flow Growth | 116.47 | 27.82 | 110.45 | 4.03 | -73.42 | -125.88 |
Free Cash Flow Growth | 77.08% | -74.81% | 2641.28% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.70% | 57.38% | 51.48% | 34.45% | 22.89% | 1.45% |
Operating Margin | 42.26% | 37.52% | 32.59% | 8.65% | -25.55% | -71.13% |
Pretax Margin | 42.26% | 35.80% | 29.48% | -10.94% | -42.77% | -88.52% |
Profit Margin | 32.98% | 28.80% | 46.35% | -10.94% | -42.77% | -88.52% |
FCF Margin | 22.74% | 5.45% | 25.90% | 1.56% | -47.65% | -155.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.52 | 29.55 | 20.51 | - | - | - |
Forward PE | 10.64 | 22.24 | 25.28 | 36.16 | - | - |
P/FCF Ratio | 18.21 | 156.04 | 36.71 | 253.51 | - | - |
PS Ratio | 4.14 | 8.51 | 9.51 | 3.96 | 5.56 | 3.41 |